Literature DB >> 1673511

Lack of eradication of Helicobacter pylori after omeprazole.

E A Rauws, W Langenberg, A Bosma, J Dankert, G N Tytgat.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1673511     DOI： 10.1016/0140-6736(91)91737-f

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  9 in total

1.  In vitro susceptibility of Helicobacter pylori to nitecapone.

Authors:  H Rautelin; O V Renkonen; T V Kosunen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-03       Impact factor: 3.267

Review 2.  Omeprazole: a pharmacoeconomic evaluation of its use in duodenal ulcer and reflux oesophagitis.

Authors:  L B Barradell; D McTavish
Journal:  Pharmacoeconomics       Date:  1993-06       Impact factor: 4.981

Review 3.  Gastroenterology--I: Gastroduodenal disease and Helicobacter pylori.

Authors:  M C Bateson
Journal:  Postgrad Med J       Date:  1994-08       Impact factor: 2.401

Review 4.  Omeprazole. An updated review of its pharmacology and therapeutic use in acid-related disorders.

Authors:  D McTavish; M M Buckley; R C Heel
Journal:  Drugs       Date:  1991-07       Impact factor: 9.546

Review 5.  A risk-benefit assessment of drugs used in the eradication of Helicobacter pylori infection.

Authors:  A Hackelsberger; P Malfertheiner
Journal:  Drug Saf       Date:  1996-07       Impact factor: 5.606

6.  DNA fingerprints of Helicobacter pylori before and after treatment with omeprazole.

Authors:  A G Fraser; J Bickley; R J Owen; R E Pounder
Journal:  J Clin Pathol       Date:  1992-12       Impact factor: 3.411

Review 7.  Effects of acid suppression on microbial flora of upper gut.

Authors:  N D Yeomans; R W Brimblecombe; J Elder; R V Heatley; J J Misiewicz; T C Northfield; A Pottage
Journal:  Dig Dis Sci       Date:  1995-02       Impact factor: 3.199

8.  Omeprazole may exert both a bacteriostatic and a bacteriocidal effect on the growth of Helicobacter pylori (NCTC 11637) in vitro by inhibiting bacterial urease activity.

Authors:  F Mirshahi; G Fowler; A Patel; G Shaw
Journal:  J Clin Pathol       Date:  1998-03       Impact factor: 3.411

Review 9.  Omeprazole. An update of its pharmacology and therapeutic use in acid-related disorders.

Authors:  M I Wilde; D McTavish
Journal:  Drugs       Date:  1994-07       Impact factor: 9.546
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.